FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe
In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients
First Compound From New In Vitro Screening to Enter Clinical Trials
DCBD Board Okays Concept for Animal Holding Recompetition
Minorities Increasingly Involved In Research, Training Programs
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center









